Targeting the retinal microcirculation to treat diabetic sight problems.

Item

http://www.wikidata.org/entity/Q37008851

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Targeting the retinal microcirculation to treat diabetic sight problems.

@en

Targeting the retinal microcirculation to treat diabetic sight problems.

@nl

type

Item

label

Targeting the retinal microcirculation to treat diabetic sight problems.

@en

Targeting the retinal microcirculation to treat diabetic sight problems.

@nl

prefLabel

Targeting the retinal microcirculation to treat diabetic sight problems.

@en

Targeting the retinal microcirculation to treat diabetic sight problems.

@nl

P1476

Targeting the retinal microcirculation to treat diabetic sight problems.

@en

P2093

Dieuwertje I Bink

http://www.w3.org/2001/XMLSchema#string

Gert Storm

http://www.w3.org/2001/XMLSchema#string

Janneke M van Blijswijk

http://www.w3.org/2001/XMLSchema#string

Marcel Ham Fens

http://www.w3.org/2001/XMLSchema#string

Raymond M Schiffelers

http://www.w3.org/2001/XMLSchema#string

P2860

Biochemistry and molecular cell biology of diabetic complications

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine

Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy.

Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.

Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels.

Medical management of diabetic retinopathy.

Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (macugen) in diabetic retinopathy.

Intravitreal triamcinolone as an adjunct in the treatment of concomitant proliferative diabetic retinopathy and diffuse diabetic macular oedema. Combined IVTA and laser treatment for PDR with CSMO.

P304

1493-1502

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.11.11.1493

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18028012

http://www.w3.org/2001/XMLSchema#string